Victory Capital Management Inc. Has $11.28 Million Stock Holdings in Patterson Companies, Inc. (NASDAQ:PDCO)

Victory Capital Management Inc. decreased its stake in Patterson Companies, Inc. (NASDAQ:PDCO) by 4.8% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 365,436 shares of the company’s stock after selling 18,513 shares during the period. Victory Capital Management Inc. owned about 0.41% of Patterson Companies worth $11,277,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also added to or reduced their stakes in the stock. Equity Investment Corp raised its stake in shares of Patterson Companies by 16.6% during the fourth quarter. Equity Investment Corp now owns 2,028,964 shares of the company’s stock valued at $62,614,000 after acquiring an additional 289,295 shares during the last quarter. Charles Schwab Investment Management Inc. grew its holdings in shares of Patterson Companies by 15.8% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,799,942 shares of the company’s stock valued at $55,546,000 after buying an additional 245,376 shares during the last quarter. Bank of New York Mellon Corp grew its holdings in shares of Patterson Companies by 18.0% during the fourth quarter. Bank of New York Mellon Corp now owns 1,455,729 shares of the company’s stock valued at $44,924,000 after buying an additional 222,005 shares during the last quarter. Allianz Asset Management GmbH boosted its holdings in Patterson Companies by 3.7% during the fourth quarter. Allianz Asset Management GmbH now owns 1,186,906 shares of the company’s stock worth $36,628,000 after purchasing an additional 42,689 shares during the last quarter. Finally, Goodman Financial Corp boosted its holdings in Patterson Companies by 19.1% during the third quarter. Goodman Financial Corp now owns 543,282 shares of the company’s stock worth $11,865,000 after purchasing an additional 86,972 shares during the last quarter. Institutional investors own 85.43% of the company’s stock.

Analysts Set New Price Targets

Several analysts have commented on PDCO shares. Robert W. Baird lifted their price objective on shares of Patterson Companies from $25.00 to $31.00 and gave the stock a “neutral” rating in a research report on Thursday, December 12th. Leerink Partners reissued a “market perform” rating and issued a $31.35 price target (up previously from $29.00) on shares of Patterson Companies in a research note on Wednesday, December 11th. Piper Sandler cut their price objective on shares of Patterson Companies from $26.00 to $24.00 and set a “neutral” rating for the company in a research note on Friday, December 6th. Stifel Nicolaus lowered their price target on shares of Patterson Companies from $25.00 to $24.00 and set a “hold” rating for the company in a report on Thursday, December 5th. Finally, Morgan Stanley upped their price objective on shares of Patterson Companies from $27.00 to $31.35 and gave the stock an “equal weight” rating in a report on Tuesday, December 17th. Eleven equities research analysts have rated the stock with a hold rating and one has assigned a buy rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Hold” and an average target price of $26.57.

Patterson Companies Stock Performance

Shares of PDCO stock opened at $31.14 on Friday. Patterson Companies, Inc. has a one year low of $19.45 and a one year high of $31.79. The company’s 50-day moving average is $31.00 and its 200 day moving average is $25.85. The company has a market capitalization of $2.76 billion, a price-to-earnings ratio of 18.21, a price-to-earnings-growth ratio of 2.71 and a beta of 0.99. The company has a debt-to-equity ratio of 0.34, a quick ratio of 0.76 and a current ratio of 1.37.

About Patterson Companies

Patterson Companies, Inc engages in the distribution of dental and animal health products in the United States, the United Kingdom, and Canada. The company operates through three segments: Dental, Animal Health, and Corporate segments. The Dental segment offers consumable products, including infection control, restorative materials, and instruments; basic and advanced technology and dental equipment; practice optimization solutions, such as practice management software, e-commerce, revenue cycle management, patient engagement solutions, and clinical and patient education systems.